Marble Harbor Investment Counsel LLC Buys 2,687 Shares of Danaher Corporation $DHR

Marble Harbor Investment Counsel LLC grew its position in Danaher Corporation (NYSE:DHR) by 12.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 24,084 shares of the conglomerate’s stock after purchasing an additional 2,687 shares during the period. Marble Harbor Investment Counsel LLC’s holdings in Danaher were worth $4,758,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of DHR. Nuveen LLC acquired a new position in Danaher in the 1st quarter worth $833,941,000. Generation Investment Management LLP grew its position in Danaher by 56.2% in the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock valued at $980,914,000 after purchasing an additional 1,787,522 shares in the last quarter. Invesco Ltd. lifted its position in Danaher by 44.5% during the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock worth $965,259,000 after buying an additional 1,450,703 shares in the last quarter. Baird Financial Group Inc. boosted its stake in shares of Danaher by 290.6% during the 1st quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock worth $295,550,000 after buying an additional 1,072,617 shares during the last quarter. Finally, Parnassus Investments LLC grew its holdings in shares of Danaher by 23.3% in the 1st quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock valued at $784,745,000 after acquiring an additional 722,636 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on DHR shares. Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a research report on Thursday, October 23rd. Cowen reiterated a “buy” rating on shares of Danaher in a research note on Wednesday, October 22nd. Barclays boosted their target price on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. JPMorgan Chase & Co. increased their price target on shares of Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, TD Cowen lifted their price target on Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $243.39.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is owned by corporate insiders.

Danaher Trading Up 2.2%

Shares of Danaher stock opened at $215.80 on Wednesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The firm has a 50-day moving average of $204.36 and a 200-day moving average of $200.64. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23. The stock has a market cap of $152.43 billion, a PE ratio of 44.49, a PEG ratio of 3.28 and a beta of 0.81.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business’s revenue was up 4.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s payout ratio is 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.